Beam Therapeutics, Inc. (BEAM)

27.61 -0.27 (-0.97%) USD  |  NASDAQ  |  Feb 20, 15:55
More

Beam Therapeutics Underperform Recommendations

Underperform Recommendations Chart

View Underperform Recommendations for BEAM.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Underperform Recommendations Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Underperform Recommendations Range, Past 5 Years

View Underperform Recommendations Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Underperform Recommendations Benchmarks

View Underperform Recommendations Benchmarks
Start Trial
Twist Bioscience Corp. Upgrade
Intellia Therapeutics, Inc. Upgrade
Pacific Biosciences of California, Inc. Upgrade
Regeneron Pharmaceuticals, Inc. Upgrade
Ionis Pharmaceuticals, Inc. Upgrade